This Article Full Text Full Text (PDF) Supplementary Data, Coleman, et al. Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scarpini, C. Articles by Coleman, N. Search for Related Content PubMed PubMed Citation Articles by Scarpini, C. Articles by Coleman, N.

Improved Screening for Anal Neoplasia by Immunocytochemical Detection of Minichromosome Maintenance Proteins

¹ Medical Research Council Cancer Cell Unit; Departments of ² Surgery and ³ Histopathology, Addenbrooke's Hospital, Cambridge, United Kingdom; ⁴ Department of Sexual Health, Homerton University Hospital NHS Foundation Trust; ⁵ Department of Histopathology, Barts and the London NHS Trust; and ⁶ Department of Surgery, Royal Free and University College Medical School, London, United Kingdom

Requests for reprints: Nicholas Coleman, Medical Research Council Cancer Cell Unit, Hutchison/Medical Research Council Research Centre, Hills Road, Cambridge CB2 0XZ, United Kingdom. Phone: 44-1223-763285; Fax: 44-1223-763284. E-mail: nc109{at}cam.ac.uk

Purpose: Early detection of anal intraepithelial neoplasia (AIN) and anal squamous cell carcinoma (SCC) by screening will improve clinical outcome. Assessment of anal cytology samples using routine Papanicolaou testing suffers from shortcomings in sensitivity and/or specificity, suggesting that screening tests based on biomarkers may be of value. We tested the suitability in this context of minichromosome maintenance (MCM) proteins, accurate markers of the deregulated cell cycle entry that characterizes malignancy and premalignancy.

Experimental Design: We undertook an initial immunohistochemical study of 54 anal tissue samples and validated our findings using an independent prospective cohort study of 235 anal cytology samples from 144 subjects.

Results: In the progression from normal anal epithelium through AIN to SCC, there was increasing expression of MCM2 and MCM5, including in the superficial epithelial third, the source of the majority of cells collected by anal swab. The median labeling indices (LI) for MCM2 and MCM5 in the superficial third of AIN2/3 and SCCs combined were 90.2% and 84.0%, respectively. MCM LIs in the superficial layers were significantly greater than LIs for Ki67, an alternative marker of cell cycle entry (P < 0.0001). By immunocytochemistry using a mixture of anti-MCM2 and anti-MCM5 antibodies, immunopositive cells were readily identified in anal cytology samples, even at low magnification. MCM testing showed sensitivity for AIN2/3 of 84% (95% confidence interval, 75,93) and for AIN1/viral changes of 76% (68, 84), with overall specificity (for any lesion) of 77% (64, 90).

Conclusions: MCMs are promising biomarkers for improving detection of AIN and SCC in anal cytology samples. (Cancer Epidemiol Biomarkers Prev 2008;17(10):2855–64)

This article has been cited by other articles:

				R. W. Shultz, T.-J. Lee, G. C. Allen, W. F. Thompson, and L. Hanley-Bowdoin Dynamic Localization of the DNA Replication Proteins MCM5 and MCM7 in Plants Plant Physiology, June 1, 2009; 150(2): 658 - 669. [Abstract] [Full Text] [PDF]